Tag: cancer tumor profiling market

  • 2024-2033 Cancer Tumor Profiling Market: Key Insights on Growth Opportunities

    2024-2033 Cancer Tumor Profiling Market: Key Insights on Growth Opportunities

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Cancer Tumor Profiling Market from 2024 to 2033?

    The cancer tumor profiling market has seen rapid growth in recent years. It will increase from $11.17 billion in 2023 to $12.93 billion in 2024, at a CAGR of 15.7%. The rise in cancer incidence, advancements in precision medicine, improved diagnostic methods, a range of targeted therapies, and supportive regulatory frameworks have driven this growth.

    The cancer tumor profiling market is expected to reach $22.06 billion by 2028, growing at a CAGR of 14.3%. Growth drivers include immunotherapy expansion, liquid biopsy methods, single-cell sequencing, early detection programs, and demand for rare cancer profiling. Trends include multi-omics approaches, AI integration, personalized medicine, and advances in genomics and sequencing.

    Claim Your Free Sample of the Global Cancer Tumor Profiling Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=6053&type=smp

    What Key Factors Are Fueling the Growth of the Cancer Tumor Profiling Market?

    The rising incidence of cancer globally is expected to propel the cancer and tumor profiling market. With cancer cases increasing, there is a growing need for profiling to assess disease severity. According to the American Cancer Society, approximately 1.8 million new cancer cases were diagnosed in 2020, driving the demand for tumor profiling solutions to improve patient outcomes.

    What Are the Major Segments of the Cancer Tumor Profiling Market?

    1) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types

    2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies

    3) By Process Type: Genomics, Proteomics, Epigenetics, Metabolomics, Other Types

    4) By Application: Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications

    What New Trends Are Transforming the Cancer Tumor Profiling Market?

    The cancer and tumor profiling market is seeing an increase in research and development activities. Companies in this sector are focusing on R&D to meet consumer demands and strengthen their market position. For instance, QIAGEN N.V. received CE marking for its therascreen PIK3CA RGQ PCR Kit, which helps identify breast cancer patients with PIK3CA mutations, offering testing on both plasma specimens and FFPE tissue.

    Order Now for Fast Delivery of Your Cancer Tumor Profiling Market Report!

    https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

    Which Regions Are Driving Growth in the Cancer Tumor Profiling Market?

    North America was the largest region in cancer and tumor profiling market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer tumor profiling market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    The Cancer Tumor Profiling Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the cancer tumor profiling market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Cancer Tumor Profiling Market Include

    1. Cancer Tumor Profiling Market Executive Summary

    2. Cancer Tumor Profiling Market Segments

    3. Cancer Tumor Profiling Market Size And Template Market Growth Rate

    4. Key Cancer Tumor Profiling Market Trends

    5. Major Cancer Tumor Profiling Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Cancer Tumor Profiling Market

    26. Top Cancer Tumor Profiling Companies

    27. Cancer Tumor Profiling Market Opportunities And Strategies

    28. Cancer Tumor Profiling Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

    Industry:

    Healthcare Services

    Meta Keywords:

    cancer tumor profiling market, cancer tumor profiling market size, cancer tumor profiling market share, cancer tumor profiling market trends, cancer tumor profiling market growth, cancer tumor profiling market forecast, global cancer tumor profiling market, worlwide cancer tumor profiling market size, cancer tumor profiling market research report, cancer tumor profiling market growth drivers, cancer tumor profiling market opportunities

    The Business Research Company offers the cancer tumor profiling market research report 2024 with industry size, share, segments and market growth

    Global Cancer Tumor Profiling Market, Global Cancer Tumor Profiling Market Report, Global Cancer Tumor Profiling Market Trends, Global Cancer Tumor Profiling Market Size

  • 5 Key Insights On The Cancer Tumor Profiling Market 2024

    5 Key Insights On The Cancer Tumor Profiling Market 2024

     The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Cancer Tumor Profiling Global Market Report 2024, the cancer tumor profiling market is expected to show significant growth in the forecast period.

    The cancer tumor profiling market has witnessed substantial growth in recent years, with the market size reaching $11.17 billion in 2023. This growth is projected to continue, reaching $12.93 billion in 2024 at a notable compound annual growth rate (CAGR) of 15.7%. The drivers for this expansion in the historic period include:

    • Increasing cancer incidence
    • Growth in precision medicine initiatives and research collaborations
    • Improved cancer diagnostics and early detection methods
    • Availability of a wide range of targeted therapy options
    • Supportive regulatory frameworks for cancer profiling tests

    A Glimpse into the Future
    Looking ahead, the market is expected to experience even more robust growth, reaching $22.06 billion in 2028 at a CAGR of 14.3%. The forecasted growth is attributed to:

    • Expansion of immunotherapy and immunoprofiling in cancer treatment
    • Development of liquid biopsy and non-invasive tumor profiling methods
    • Adoption of single-cell sequencing for more detailed tumor characterization
    • Expansion of cancer screening and early detection programs
    • Increasing demand for rare and orphan cancer subtype profiling

    Major Trends Shaping the Future Landscape
    The forecast period brings forth significant trends that will shape the cancer tumor profiling market:

    • Integration of tumor profiling into routine clinical practice
    • Advances in multi-omics approaches
    • Integration of artificial intelligence (AI) and machine learning in data analysis
    • Personalized medicine and targeted therapy development
    • Advances in genomics and next-generation sequencing (NGS) technologies

    Key Drivers of Market Growth
    Rising Incidences of Cancer Across the Globe
    The surge in cancer cases globally is a primary driver of the growth in the cancer and tumor profiling market. As the number of cancer cases continues to rise, there is a proportional increase in the demand for tumor profiling to assess disease severity. For instance:

    • According to the American Cancer Society, 1.8 million new cancer cases were diagnosed in 2020.
    • Increasing incidences of cancer worldwide contribute significantly to the growth of the cancer and tumor profiling market.

    Companies Powering the Market
    Major players driving the market forward include:

    • F. Hoffmann-La Roche Ltd.
    • Caris Life Sciences
    • Thermo Fisher Scientific Inc.
    • Illumina Inc.
    • Qiagen
    • Ribomed Biotechnologies Inc.
    • HTG Molecular Diagnostics Inc.
    • NanoString Technologies Inc.
    • NeoGenomics Laboratories Inc.
    • Lucence Health Inc.

    View More On The Cancer Tumor Profiling Market Report 2024 – https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

    Research and Development Fueling Innovation
    Increasing Research and Development Activities
    A prominent trend in the cancer and tumor profiling market is the emphasis on research and development activities by major companies. These activities are aimed at meeting consumer demands and reinforcing market positions. For example:

    • QIAGEN N.V., a German company, announced the CE-marking and commercialization of therascreen PIK3CA RGQ PCR Kit in Europe, aiding in the identification of breast cancer patients with PIK3CA mutations.
    • The therascreen PIK3CA test is a diagnostic assay for detecting activating mutations in the PIK3CA gene, allowing testing of both DNA from plasma specimens or FFPE tissue.

    Strategic Acquisitions Boosting Market Dynamics
    In June 2023, Quest Diagnostics, a leading US-based medical laboratory company, acquired Haystack Oncology Inc. for $450 million. This strategic move aims to:

    • Expand access to liquid biopsy technology
    • Increase market share in cancer diagnostics
    • Enhance research and development capabilities

    Market Segmentation for Precision Targeting
    The cancer tumor profiling market is segmented based on various criteria:

    1. By Cancer Type:
      • Lung Cancer
      • Breast Cancer
      • Colorectal Cancer
      • Prostate Cancer
      • Melanoma
      • Ovarian Cancer
      • Stomach Cancer
      • Pancreatic Cancer
      • Thyroid Cancer
      • Other Cancer Types
    2. By Technology:
      • Next-Generation Sequencing (NGS)
      • Polymerase Chain Reaction (PCR)
      • Immunohistochemistry (IHC)
      • In Situ Hybridization (ISH)
      • Microarray
      • Other Technologies
    3. By Process Type:
      • Genomics
      • Proteomics
      • Epigenetics
      • Metabolomics
      • Other Types
    4. By Application:
      • Personalized Medicine
      • Diagnostics
      • Biomarker Discovery
      • Prognostics
      • Research Applications

    Geographical Dynamics
    North America led the cancer and tumor profiling market in 2023, with Asia-Pacific anticipated to be the fastest-growing region in the forecast period.

    In conclusion, the cancer tumor profiling market is set to witness remarkable growth, driven by factors such as rising cancer incidences, innovative research and development activities, strategic acquisitions, and advancements in technologies. The market’s evolution promises a future where precision medicine and targeted therapies become increasingly integral to cancer diagnosis and treatment.

    Request A Sample Of The Global Cancer Tumor Profiling Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=6053&type=smp